Research To Practice | Oncology Videos

Latest Episodes:

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists Nov 16, 2022

Show notes

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas. Featuring perspectives from Drs Ann LaCasce and Mitchell Smith, including the following topics:

Hodgkin Lymphoma and CLL (0:00)
Bispecific Antibodies, CAR T-Cell Therapy; Diffuse Large B-Cell Lymphoma (32:31)
Treatment for Mantle Cell Lymphoma (53:23)

CME information and select publications

Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists Nov 16, 2022

Show notes

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in lung cancer. Featuring perspectives from Drs Corey Langer and Christine Lovly, including the following topics:

First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) in Patients without Targetable Mutations (0:00)
Neoadjuvant and Adjuvant Treatment of Localized NSCLC (14:29)
Targeted Treatment of Metastatic NSCLC (32:44)

CME information and select publications

Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes Nov 15, 2022

Show notes

Featuring an interview with Dr Amy DeZern, including the following topics:

Case: A man in his mid 60s with myelodysplastic syndromes (MDS) and comorbid psoriatic arthritis and osteoarthritis (0:00)
Association between autoimmune conditions and MDS; impact of coexisting autoimmune disease on MDS treatment selection (7:55)
Case: A man in his late 50s presenting with a chronic cough and cytopenia (15:10)
Case: A woman in her early 70s with significant weight loss, fatigue and night sweats (21:06)
MDS risk evaluation and stratification; optimal management of secondary MDS; treatment options for MDS progressing to acute myeloid leukemia (28:31)
Myths and misperceptions about MDS among general medical oncologists; novel agents under evaluation for MDS (34:17)
Considerations for off-label use of venetoclax for high-risk MDS; clinical pearls about managing low-risk MDS (39:00)

CME information and select publications

Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes (Companion Faculty Lecture) Nov 15, 2022

Show notes

Featuring a slide presentation and related discussion from Dr Amy DeZern, including the following topics:

Classification of myelodysplastic syndromes (MDS) (0:00)
Available data with and optimal selection of commericially available therapies for MDS (6:54)
Emerging data with novel MDS therapies from clinical trials (21:34)

CME information and select publications

Multiple Myeloma| BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 1 Nov 11, 2022

Show notes

Featuring perspectives from Dr Elizabeth O'Donnell, including the following topics:

Introduction: Quality of Life in Multiple Myeloma (0:00)
CAR (Chimeric Antigen Receptor) T-Cell Therapy (9:29)
Bispecific Antibodies (33:08)
Belantamab Mafodotin (43:11)

CME information and select publications

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences (Companion Faculty Lecture) Nov 10, 2022

Show notes

Featuring a slide presentation and related discussion from Dr Rachna Shroff, including the following topics:

Colorectal Cancer (0:00)
Gastroesophageal Cancers (19:20)
Hepatocellular Carcinoma (27:20)
Biliary Tract Cancers (37:59)
Pancreatic Cancer (41:33)

CME information and select publications

Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences Nov 10, 2022

Show notes

Featuring an interview with Dr Rachna Shroff, including the following topics:

Novel targets and emerging strategies for the treatment of pancreatic cancer (0:00)
Current and emerging approaches to the care of patients with biliary tract cancers (6:28)
Efficacy and tolerability of approved and investigational therapies for hepatocellular carcinoma ()18:42)
Incorporating immuno-oncology agents and targeted strategies into the care of patients with gastroesophageal cancer (28:07)
Evaluating current and emerging targeted approaches to the treatment of colorectal cancer (35:28)

CME information and select publications

Prostate Cancer | Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1 Nov 09, 2022

Show notes

Featuring perspectives from Dr Matthew Smith, including the following topics:

Introduction: Abemaciclib for Prostate Cancer? (0:00)
Case: A man in his early 70s with a PSA of 150 ng/mL, Gleason 4 + 4 and upper abdominal adenopathy — Jennifer L Dallas, MD (9:30)
Case: A man in his late 60s with Gleason 4 + 4, PSA of 147 ng/mL and a negative CT — David S Morris, MD (34:30)
Case: A man in his late 60s with coronary artery disease and Gleason 4 + 4 who underwent external beam radiation therapy (EBRT) in 2013 and now has increasing PSA of 3.8 with a 6-month doubling time — Gurveen Kaur, MD (37:56)
Case: A man in his mid 60s who experiences M0 progression after EBRT followed by androgen deprivation therapy (ADT) but refuses to continue ADT — Henna Malik, MD (41:44)
Case: A man in his early 50s with a slowly rising PSA (now 1.31) after radical prostatectomy and salvage radiation therapy; PSMA PET scan denied by insurance, now appealed — Kapisthalam (KS) Kumar, MD (50:23)
Case: A man in his late 70s with Gleason 5 + 4 and a PSA of 23 ng/mL increasing after EBRT followed by ADT, cryoablation and enzalutamide; after a response, 18F-fluciclovine PET shows subtle focus of uptake in left prostate — Susmitha Apuri, MD (57:06)

CME information and select publications

Chronic Lymphocytic Leukemia | Challenging Cases from Junior Investigators: The Application of Available and Emerging Clinical Research in the Care of Patients with Chronic Lymphocytic Leukemia Nov 08, 2022

Show notes

Featuring perspectives from Drs Danielle Brander, Matthew Davids, Anthony Mato and William Wierda, including the following topics:

Front-Line Chronic Lymphocytic Leukemia (CLL; Standard-Risk Patients) — Anthony R Mato, MD, MSCE (0:00)
CLL in 2022: Front-Line Therapy for Patients with High-Risk Disease — Danielle Brander, MD (28:50)
Fixed-Duration Targeted Therapy for CLL — William G Wierda, MD, PhD (59:26)
Novel Investigational Agents and Strategies for CLL — Matthew S Davids, MD, MMSc (1:13:11)

CME information and select publications

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer (Companion Faculty Lecture) Nov 07, 2022

Show notes

Featuring a slide presentation and related discussion from Dr Rebecca Heist, including the following topics:

Targeting MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) (0:00)
Efficacy and tolerability of MET tyrosine kinase inhibitors in patients with NSCLC and MET alterations (12:35)
Mechanisms of resistance to therapies for MET-altered NSCLC (19:11)
Evaluating the role of antibody-based therapy in the treatment of MET-altered NSCLC (25:17)

CME information and select publications